VSeq-Toolkit: Comprehensive Computational Analysis of Viral Vectors in Gene Therapy

[1]  Paola Bonizzoni,et al.  γ-TRIS: a graph-algorithm for comprehensive identification of vector genomic insertion sites , 2019, Bioinform..

[2]  Martin J. Aryee,et al.  High levels of AAV vector integration into CRISPR-induced DNA breaks , 2019, Nature Communications.

[3]  S. Freeman,et al.  Novel stem cell and gene therapy in diabetic retinopathy, age related macular degeneration, and retinitis pigmentosa , 2019, International Journal of Retina and Vitreous.

[4]  D. Grimm,et al.  AAV vector-mediated in vivo reprogramming into pluripotency , 2018, Nature Communications.

[5]  E. Steinhagen-Thiessen,et al.  Gene Therapy in Lipoprotein Lipase Deficiency: Case Report on the First Patient Treated with Alipogene Tiparvovec Under Daily Practice Conditions. , 2018, Human gene therapy.

[6]  G. Ronzitti,et al.  Emerging Issues in AAV-Mediated In Vivo Gene Therapy , 2017, Molecular therapy. Methods & clinical development.

[7]  L. Milanesi,et al.  VISPA2: a scalable pipeline for high-throughput identification and annotation of vector integration sites , 2017, BMC Bioinformatics.

[8]  Surbhi Jain,et al.  ChimericSeq: An open-source, user-friendly interface for analyzing NGS data to identify and characterize viral-host chimeric sequences , 2017, PloS one.

[9]  J. Glorioso,et al.  A brief account of viral vectors and their promise for gene therapy , 2017, Gene Therapy.

[10]  Kyle Bittinger,et al.  INSPIIRED: Quantification and Visualization Tools for Analyzing Integration Site Distributions , 2016, Molecular therapy. Methods & clinical development.

[11]  Christof von Kalle,et al.  GENE-IS: Time-Efficient and Accurate Analysis of Viral Integration Events in Large-Scale Gene Therapy Data , 2016, Molecular therapy. Nucleic acids.

[12]  A. Zamyatnin,et al.  Viral vectors for gene therapy: Current state and clinical perspectives , 2016, Biochemistry (Moscow).

[13]  Johannes C. M. van der Loo,et al.  Progress and challenges in viral vector manufacturing. , 2016, Human molecular genetics.

[14]  O. Merten,et al.  Towards routine manufacturing of gene therapy drugs , 2016, Molecular therapy. Methods & clinical development.

[15]  Luigi Naldini,et al.  Gene therapy returns to centre stage , 2015, Nature.

[16]  S. Szymczak,et al.  Vy-PER: eliminating false positive detection of virus integration events in next generation sequencing data , 2015, Scientific Reports.

[17]  Daniel G. Miller,et al.  VISA - Vector Integration Site Analysis server: a web-based server to rapidly identify retroviral integration sites from next-generation sequencing , 2015, BMC Bioinformatics.

[18]  Daniel Ho,et al.  Virus-Clip: a fast and memory-efficient viral integration site detection tool at single-base resolution with annotation capability , 2015, Oncotarget.

[19]  C. von Kalle,et al.  Preclinical Evaluation of Efficacy and Safety of an Improved Lentiviral Vector for the Treatment of β-Thalassemia and Sickle Cell Disease , 2014, Current gene therapy.

[20]  Shuifang Zhu,et al.  Skewer: a fast and accurate adapter trimmer for next-generation sequencing paired-end reads , 2014, BMC Bioinformatics.

[21]  F. Cremers,et al.  Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial , 2014, The Lancet.

[22]  C. von Kalle,et al.  Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy , 2013, Science.

[23]  Adam Bagg,et al.  Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma. , 2013, Blood.

[24]  Zhongming Zhao,et al.  VirusFinder: Software for Efficient and Accurate Detection of Viruses and Their Integration Sites in Host Genomes through Next Generation Sequencing Data , 2013, PloS one.

[25]  John N. Weinstein,et al.  VirusSeq: software to identify viruses and their integration sites using next-generation sequencing of human cancer tissue , 2013, Bioinform..

[26]  Christof von Kalle,et al.  Integration Frequency and Intermolecular Recombination of rAAV Vectors in Non-human Primate Skeletal Muscle and Liver. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[27]  Christof von Kalle,et al.  Bioinformatic clonality analysis of next-generation sequencing-derived viral vector integration sites. , 2012, Human gene therapy methods.

[28]  Chuanfeng Wu,et al.  Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity , 2011, Frontiers of medicine.

[29]  Aaron R. Quinlan,et al.  BIOINFORMATICS APPLICATIONS NOTE , 2022 .

[30]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[31]  Christine Kinnon,et al.  Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. , 2008, The Journal of clinical investigation.

[32]  F. Bushman,et al.  Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. , 2008, The Journal of clinical investigation.

[33]  Hanno Glimm,et al.  High-resolution insertion-site analysis by linear amplification–mediated PCR (LAM-PCR) , 2007, Nature Methods.

[34]  W. Godbey,et al.  Viral vectors for gene delivery in tissue engineering. , 2006, Advanced drug delivery reviews.

[35]  J. B. Connolly,et al.  Lentiviruses in gene therapy clinical research , 2002, Gene Therapy.

[36]  Claude-Alain H. Roten,et al.  Theoretical and practical advances in genome halving , 2004 .